Antitumor effects of specific telomerase inhibitor GRN163 in human glioblastoma xenografts. Read more about Antitumor effects of specific telomerase inhibitor GRN163 in human glioblastoma xenografts.
Prognostic factors for survival of patients with glioblastoma: recursive partitioning analysis. Read more about Prognostic factors for survival of patients with glioblastoma: recursive partitioning analysis.
Refining the staging evaluation of pineal region germinoma using neuroendoscopy and the presence of preoperative diabetes insipidus. Read more about Refining the staging evaluation of pineal region germinoma using neuroendoscopy and the presence of preoperative diabetes insipidus.
Analysis of 1p, 19q, 9p, and 10q as prognostic markers for high-grade astrocytomas using fluorescence in situ hybridization on tissue microarrays from Radiation Therapy Oncology Group trials. Read more about Analysis of 1p, 19q, 9p, and 10q as prognostic markers for high-grade astrocytomas using fluorescence in situ hybridization on tissue microarrays from Radiation Therapy Oncology Group trials.
Permanent iodine 125 brachytherapy in patients with progressive or recurrent glioblastoma multiforme. Read more about Permanent iodine 125 brachytherapy in patients with progressive or recurrent glioblastoma multiforme.
Phase 2 study of BCNU and temozolomide for recurrent glioblastoma multiforme: North American Brain Tumor Consortium study. Read more about Phase 2 study of BCNU and temozolomide for recurrent glioblastoma multiforme: North American Brain Tumor Consortium study.
Phase 1 trial of irinotecan (CPT-11) in patients with recurrent malignant glioma: a North American Brain Tumor Consortium study. Read more about Phase 1 trial of irinotecan (CPT-11) in patients with recurrent malignant glioma: a North American Brain Tumor Consortium study.
O6-benzylguanine suppression of O6-alkylguanine-DNA alkyltransferase in anaplastic gliomas. Read more about O6-benzylguanine suppression of O6-alkylguanine-DNA alkyltransferase in anaplastic gliomas.
Pathology of low-grade gliomas: an update of emerging concepts. Read more about Pathology of low-grade gliomas: an update of emerging concepts.
A randomized, double-blind, placebo-controlled, phase 2 study of RMP-7 in combination with carboplatin administered intravenously for the treatment of recurrent malignant glioma. Read more about A randomized, double-blind, placebo-controlled, phase 2 study of RMP-7 in combination with carboplatin administered intravenously for the treatment of recurrent malignant glioma.
